HTR1A and psychiatric disorder: Animal studies demonstrated the anxiolytic effects of yokukansan via 5‐HT1A and 5‐HT2A receptors,6, 8 suggesting yokukansan as a prospective therapeutic modality for anxiety disorders and a variety of psychiatric disorders that co‐occur with anxiety.